New grid tech aims to sharpen cancer scans
NCT ID NCT04565457
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 35 times
Summary
This study tested whether a special grid (2D antiscatter grid) can improve the quality of cone beam CT (CBCT) images used during radiation therapy for prostate, head/neck, and upper abdomen cancers. Researchers compared standard CBCT images to those taken with the new grid in 43 participants. The goal was to see if the grid reduces image errors and improves tissue visibility, which could help doctors target tumors more accurately.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
-
University of Florida Health Proton Therapy Institute
Jacksonville, Florida, 32206, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.